The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...

Acquired resistance genes may allow bacteria to degrade or chemically modify antibiotics, rendering them ineffective. They ...

Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution.

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable ...

Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...

Ph.D., Elutia’s Chief Scientific Officer. “The results demonstrate the robust antimicrobial performance of antibiotic-eluting biologic envelopes in a rigorous model. We believe these new data ...

Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics for the first ...

What is the effectiveness of antibiotics in treating acute appendicitis compared to surgery? The results of the first international study on the subject have just been published in the scientific ...